Literature DB >> 25444124

[Distribution of phylogenetic groups and virulence factors in CTX-M-15 β-lactamase-producing uropathogenic Escherichia coli strains isolated from patients in the community of Mérida, Venezuela].

Ysheth Millán1, Erick Hernández2, Beatriz Millán1, María Araque3.   

Abstract

In this study, the distribution of phylogenetic groups and the genetic detection of virulence factors in CTX-M-15 β-lactamase-producing uropathogenic Escherichia coli (UPEC) strains were analyzed. Twenty eight strains were isolated between January 2009 and July 2011 from patients with urinary tract infection (UTI) who attended the Public Health Laboratory at Mérida, Venezuela. Determination of phylogenetic groups and detection of six virulence genes, fimH, fyuA, kpsMTII, usp, PAI and papAH, were performed by PCR amplification. Fifteen of the 28 isolates were mainly located in the phylogenetic group A, followed by B2 (12/28) and D (1/28). No direct relationship between the severity or recurrence of UTI and the distribution of phylogroups was observed. All studied virulence factors were found in group B2 strains with the highest frequency. The prevalent virulence profile included the combination of three main genes: fimH, kpsMTII and fyuA and, to a lesser extent, the presence of other determinants such as usp, PAI and/or papAH. These results indicate that virulent UPEC incorporated three important properties: adhesion, iron uptake and evasion of phagocytosis, which favored the production of recurrent UTI. This is the first report describing the association of phylogenetic groups with the potential virulence of CTX-M-15 β-lactamase producing UPEC strains in Venezuela.
Copyright © 2014 Asociación Argentina de Microbiología. Publicado por Elsevier España. All rights reserved.

Entities:  

Keywords:  Beta-lactamasa CTX-M-15; CTX-M-15 beta-lactamase; Escherichia coli uropatógena; Grupos filogenéticos; Phylogenetic groups; Uropathogenic Escherichia coli; Virulence; Virulencia

Mesh:

Substances:

Year:  2014        PMID: 25444124     DOI: 10.1016/S0325-7541(14)70069-0

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  5 in total

1.  [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].

Authors:  Victor M Blanco; Juan J Maya; Adriana Correa; Marcela Perenguez; Juan S Muñoz; Gabriel Motoa; Christian J Pallares; Fernando Rosso; Lorena Matta; Yamile Celis; Martha Garzon; María V Villegas
Journal:  Enferm Infecc Microbiol Clin       Date:  2016-01-13       Impact factor: 1.731

Review 2.  Mechanisms of Resistance in Gram-Negative Urinary Pathogens: From Country-Specific Molecular Insights to Global Clinical Relevance.

Authors:  Branka Bedenić; Tomislav Meštrović
Journal:  Diagnostics (Basel)       Date:  2021-04-28

3.  Prevalence of Fecal Carriage of CTX-M-15 Beta-Lactamase-Producing Escherichia coli in Healthy Children from a Rural Andean Village in Venezuela.

Authors:  María Araque; Indira Labrador
Journal:  Osong Public Health Res Perspect       Date:  2018-01

4.  Snapshot of Phylogenetic Groups, Virulence, and Resistance Markers in Escherichia coli Uropathogenic Strains Isolated from Outpatients with Urinary Tract Infections in Bucharest, Romania.

Authors:  Violeta Corina Cristea; Irina Gheorghe; Ilda Czobor Barbu; Laura Ioana Popa; Bogdan Ispas; Georgiana Alexandra Grigore; Irina Bucatariu; Gabriela Loredana Popa; Maria-Cristina Angelescu; Alexandra Velican; Luminita Marutescu; Marcela Popa; Mariana Carmen Chifiriuc; Ioan Mircea Popa
Journal:  Biomed Res Int       Date:  2019-05-20       Impact factor: 3.411

5.  Virulence and Resistance Determinants of Uropathogenic Escherichia coli Strains Isolated from Pregnant and Non-Pregnant Women from Two States in Mexico.

Authors:  Manuel G Ballesteros-Monrreal; Margarita Mp Arenas-Hernández; Yessica Enciso-Martínez; Claudia F Martínez-de la Peña; Rosa Del C Rocha-Gracia; Patricia Lozano-Zaraín; Armando Navarro-Ocaña; Ygnacio Martínez-Laguna; Rafael de la Rosa-López
Journal:  Infect Drug Resist       Date:  2020-01-30       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.